ReWalk Robotics Hopes to Raise $50M in IPO

From Boston Herald:

A company with U.S. headquarters in Marlborough that was recently awarded FDA approval to sell its robotic exoskeletons for paraplegics plans to raise $50 million in an IPO this week, possibly on Friday.
Israeli-based ReWalk Robotics is planning to sell 3.5 million shares for between $14 and $16 each, which puts it at the low end of the 13 local health care companies which have gone public since the beginning of the year, more than any other year in history. Most of those have been biotech companies, however, making ReWalk the first robotics-focused company to do so in at least a couple of years... (cont'd)

Comments (0)

This post does not have any comments. Be the first to leave a comment below.

Post A Comment

You must be logged in before you can post a comment. Login now.

Featured Product

1st RoboDEX - Robot Development & Application EXPO

1st RoboDEX - Robot Development & Application EXPO

RoboDEX, a comprehensive trade show for robots, will be held at the center of robot/robotics industry, Tokyo, 2017. Covering from development technology of robots to application of robots, it attracts all the professionals involved in robot industry and professionals considering utilizing robots.